E
Enlivex Ltd. (ENLV)
NCM – Real vaqt narxi. Valyuta: USD
0.75
+0.01 (0.82%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.75
+0.01 (0.82%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Enlivex Ltd. o'z sho'ba korxonalari bilan birgalikda Isroilda makrofag reprogrammasi immunoterapiyasi bo'yicha klinik bosqichda faoliyat yuritadi. U makrofag gomeostazini tiklash uchun mo'ljallangan hujayrali terapiya AllocetraTMni taklif qiladi, shuningdek, 1/2 bosqich sinovlarida bo'lgan tizza osteoartritini davolash uchun AllocetraTM intra-artikulyar in'ektsiyasini; temporomandibular bo'g'im (TMJ) osteoartritida intra-artikulyar AllocetraTMni; va 2-bosqichda bo'lgan kattalar sepsis bemorlarida organ etishmovchiligini davolash uchun Allocetra-OTSni ishlab chiqadi. Enlivex Ltd. ilgari Enlivex Therapeutics Ltd. nomi bilan tanilgan va 2026 yil fevral oyida Enlivex Ltd. nomini o'zgartirgan. Kompaniya 2005 yilda tashkil etilgan va shtab-kvartirasi Isroilning Ness Ziona shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Einat Galamidi M.D. | Chief Medical Officer |
| Dr. Oren Hershkovitz Ph.D. | Chief Executive Officer |
| Dr. Veronique Amor-Baroukh | Senior Director of Operations |
| Mr. Shai Novik M.B.A. | Executive Chairman |
| Ms. Shachar Shlosberger CPA | Chief Financial Officer |
| Ms. Sigal Arad | Director of Human Resources |
| Prof. Dror Mevorach M.D. | Founder & Scientific Advisor |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-21 | F-3 | ea0286920-f3_enlivex.htm |
| 2026-04-08 | 6-K | ea0285376-6k_enlivex.htm |
| 2026-03-26 | 6-K | ea028345301-6k_enlivex.htm |
| 2026-03-25 | 6-K | ea0283248-6k_enlivex.htm |
| 2026-03-25 | 20-F | ea0282960-20f_enlivex.htm |
| 2026-03-24 | 6-K | ea0283045-6k_enlivex.htm |
| 2026-03-23 | 6-K | ea0282900-6k_enlivex.htm |
| 2026-03-13 | S-8 | ea0281372-s8_enlivex.htm |
| 2026-02-23 | 6-K | ea0277907-6k_enlivex.htm |
| 2026-02-10 | 6-K | ea0276174-6k_enlivex.htm |